In this guide
- The short answer
- The chemistry: urea, cyanate and isocyanic acid
- What gets carbamylated, and what forms
- The mass: why +43 is not +42
- The charge it removes
- Homocitrulline versus citrulline
- Non-enzymatic, but not always permanent
- The sample-preparation artifact
- How carbamylation is detected
- The biology: inflammation, kidneys and aging
- What this guide does not establish
- Frequently asked questions
- References
The short answer
Carbamylation is a non-enzymatic modification in which isocyanic acid adds a carbamoyl group (–CO–NH₂) to a reactive group on a peptide or protein. Its signature target is the ε-amino group of a lysine side chain, which becomes homocitrulline; it also caps N-terminal amines and, reversibly, cysteine thiols. The isocyanic acid comes mainly from the slow breakdown of urea into cyanate, and the modification adds about 43 daltons.
What makes carbamylation worth a guide of its own is that it sits at the intersection of three worlds. It is a chemistry problem, because it is one of the most reliable ways to accidentally alter a protein in the laboratory. It is an analytical problem, because its +43 dalton tag is close enough to the +42 daltons of acetylation to be confused with it on a low-resolution instrument. And it is a biology problem, because the same reaction runs continuously inside living systems wherever urea is high, leaving a slow accumulation of carbamylated proteins that has been tied to kidney disease, cardiovascular disease and aging.[1][3]
The rest of this guide takes these in order: first the reaction itself and the species that drives it, then the residues it hits and the mass and charge changes it makes, then how it is distinguished from its look-alikes and measured, and finally the endogenous version of the reaction that makes it more than a nuisance. For the related chemistry of the other backbone and side-chain modifications, see What Is Citrullination, What Is Deamidation and What Is Acetylation in Peptides.
The chemistryThe chemistry: urea, cyanate and isocyanic acid
Carbamylation begins not with the protein but with urea. In water, urea does not simply dissolve and sit still; it is in a slow equilibrium with ammonium cyanate, and it is the cyanate, not the urea, that goes on to react with the protein.
The equilibrium strongly favours urea. A study of endogenous carbamylation in kidney tissue describes urea in aqueous solution as being in equilibrium with ammonium cyanate at roughly a 200-to-1 molar ratio, so only a small fraction of the urea present exists as cyanate at any moment.[2] That small fraction is continuously replenished, which is why the reaction matters over hours and days even though the instantaneous cyanate concentration is low. The accumulation of cyanate in standing urea solutions was characterised as far back as the 1960s, when it was shown to build up measurably over time.[12]
Cyanate (OCN⁻) is in equilibrium with its conjugate acid, and it is the protonated form — isocyanic acid, HNCO — that is the actual carbamylating agent. Isocyanic acid is a small, electrophilic molecule: its central carbon is hungry for electrons, so a nucleophile such as the lone pair on an amine nitrogen attacks it, and the result is a new carbon-nitrogen bond that leaves a carbamoyl group (–CO–NH₂) hanging off the nucleophile. The foundational description of cyanate reacting with the amino acids and proteins present in aqueous urea dates to work by Stark, Stein and Moore in 1960, which established the reaction that every later study builds on.[13]
Urea is not the only source. In living systems a second route runs through inflammation: the enzyme myeloperoxidase, released by activated white blood cells, oxidises the thiocyanate ion (SCN⁻) to cyanate, and related haem peroxidases and the oxidation of cyanide can do the same.[4][8][14] A third, purely metabolic source is carbamoyl phosphate, an intermediate of the urea cycle and of pyrimidine synthesis, which can transfer its carbamoyl group directly.[1] All three converge on the same chemistry: a carbamoyl group delivered to a protein nucleophile.
The targetsWhat gets carbamylated, and what forms
Carbamylation is not fussy about which amine it caps, but it has clear preferences, and the products differ in how stable they are. The reaction hits the most available nucleophiles: free amino groups and, more weakly, thiols and other side chains.
The dominant and most characteristic target is the ε-amino group at the end of a lysine side chain. When it is carbamylated, the lysine becomes homocitrulline — also written carbamyl-lysine or Nɛ-carbamoyl-lysine — a residue with a neutral ureido group in place of the original amine.[1][3] Homocitrulline is described as the most characteristic carbamylation-derived product, which is why measuring it is the standard way to quantify how much carbamylation has occurred.[3] The α-amino group at a protein's N-terminus is carbamylated by the same chemistry, and in large site-mapping experiments a substantial share of carbamylation sites turn out to be N-terminal.[2] A survey of carbamylation in kidney tissue mapped hundreds of sites across hundreds of proteins and found lysine, arginine, cysteine and protein N-termini all represented.[2]
Cysteine is a special case. Its thiol reacts with isocyanic acid to form an S-carbamyl group, but that bond is comparatively labile and can reverse, so S-carbamylation tends to be transient compared with the stable, essentially permanent cap formed on a lysine or an N-terminus.[1] Arginine, histidine and the carboxyl side chains of aspartate and glutamate can also be modified, though far less prominently than lysine. The table below summarises the main sites and their products.
| Site | Group modified | Product | Stability |
|---|---|---|---|
| Lysine side chain | ε-amino (–NH₂) | Homocitrulline (carbamyl-lysine) | Stable; the signature marker |
| Protein N-terminus | α-amino (–NH₂) | Carbamyl-N-terminus | Stable; a large share of sites |
| Cysteine | Thiol (–SH) | S-carbamyl-cysteine | Labile; can reverse |
| Arginine | Guanidinium | Carbamyl-arginine | Minor route |
| Asp / Glu | Carboxyl (–COOH) | Carbamyl-ester | Minor, unstable |
The mass: why +43 is not +42
The analytical fingerprint of carbamylation is its mass. Adding a carbamoyl group means adding the atoms of isocyanic acid — one carbon, one hydrogen, one nitrogen and one oxygen — and that defined atomic addition is what mass spectrometry reads.
The monoisotopic mass increase is about 43.0058 daltons. Proteomic datasets record it precisely as a +43.005814 dalton modification that can land on a lysine, an arginine, a cysteine or any N-terminus.[2] That value is the reason carbamylation is both easy and hard to identify. It is easy because +43 is a clean, specific tag; it is hard because it sits one dalton above acetylation, whose acetyl group adds about 42.0106 daltons.[1] A single carbamylation and a single acetylation on the same residue therefore look almost alike to a coarse measurement.
The sharper trap is isotopic. Every molecule has a cluster of isotope peaks, and the first heavy-carbon (13C) isotope peak of an acetylated peptide falls at about +43.0137 daltons — only roughly 8 millidaltons away from the +43.0058 daltons of a genuinely carbamylated peptide.[1] Separating two species eight thousandths of a dalton apart demands a high-resolution instrument; a lower-resolution one can report one as the other. This is a concrete reason the field insists on high-resolution mass spectrometry for post-translational-modification work, a theme developed in What Is Mass Spectrometry.
| Modification | Group added | Monoisotopic mass added | Note |
|---|---|---|---|
| Acetylation | Acetyl (C₂H₂O) | ≈ +42.0106 Da | Its 13C isotope peak sits near +43.014 |
| Carbamylation | Carbamoyl (CHNO) | ≈ +43.0058 Da | ~8 mDa from the acetyl isotope peak |
| Trimethylation | Three methyls, net | ≈ +42.047 Da | Isobaric with acetylation at low resolution |
| Citrullination / deamidation | –NH₂ → =O | ≈ +0.984 Da | A different, much smaller shift |
The charge it removes
Beyond its mass, carbamylation changes a protein's electrical character, and that change is often the functional point. A lysine ε-amino group is positively charged at physiological pH; capping it with a neutral carbamoyl group removes that positive charge.
Neutralising a lysine lowers the protein's net positive charge and therefore its isoelectric point, and it can change how the molecule folds, binds and behaves. Carbamylation preferentially occurs on lysine ε-amino groups, and because so many lysines across a proteome are available, a meaningful fraction can be modified over time.[3] The lost positive charge has consequences for recognition: carbamylated low-density lipoprotein, for instance, is recognised less well by its normal receptor and better by scavenger receptors, a switch that depends directly on the altered surface charge of the particle.[8] In analytical terms, a shifted charge also means a shifted mobility, so carbamylation moves a protein's position in charge-based separations such as isoelectric focusing and ion-exchange chromatography, not only its mass in a spectrometer. The way side-chain charges set a peptide's overall behaviour is covered in What Is the Isoelectric Point and What Is an Amino Acid.
A key distinctionHomocitrulline versus citrulline
Carbamylation is routinely confused with citrullination, and for a good reason: the two leave chemically similar neutral ureido groups on a protein. Telling them apart is a recurring task in both chemistry and biology, and it comes down to the starting residue and the route.
Citrullination, covered in detail in What Is Citrullination, is an enzyme-driven conversion of an arginine residue into citrulline, carried out by peptidylarginine deiminases, that removes an amine from the guanidinium group and adds only about 0.984 daltons. Carbamylation is a non-enzymatic capping of a lysine (or an N-terminus) by isocyanic acid that produces homocitrulline and adds about 43 daltons. The products are near-twins: homocitrulline, from lysine, and citrulline, from arginine, both carry a ureido group, and they differ by just a single additional methylene (CH₂) group in homocitrulline. That structural closeness is why immunological and analytical methods have to be validated specifically against one and not the other, and why anti-citrulline reagents are checked for cross-reactivity with homocitrulline. The practical separators are the mass change — a conspicuous +43 versus a subtle +1 — and the residue involved, lysine versus arginine.
| Feature | Carbamylation | Citrullination |
|---|---|---|
| Starting residue | Lysine (or N-terminus) | Arginine |
| Product | Homocitrulline | Citrulline |
| Driven by | Isocyanic acid (non-enzymatic) | PAD enzymes (enzymatic) |
| Mass change | ≈ +43.0 Da | ≈ +0.984 Da |
| Charge change | Removes a positive charge | Removes a positive charge |
Non-enzymatic, but not always permanent
Carbamylation is often described as a non-enzymatic and irreversible modification, and for the stable lysine and N-terminal products that is close to true. But the picture is more nuanced than a flat label suggests, and the nuance has turned out to be biologically interesting.
The forward reaction needs no enzyme: isocyanic acid is reactive enough to carbamylate on its own, which is exactly why it happens so readily in a test tube. The stable homocitrulline on a long-lived protein does accumulate as a near-permanent record, and the S-carbamyl product on cysteine is the main exception, being labile enough to reverse spontaneously.[1] What has changed the textbook view is the discovery of enzymatic removal: the sirtuin SIRT4 has been shown to act as a lysine decarbamylase, stripping the carbamoyl group from a specific lysine on the urea-cycle enzyme ornithine transcarbamylase and thereby tuning its activity.[1][10] Carbamylation can even be functional rather than damaging in some settings: several metal-dependent enzymes rely on a deliberately carbamylated lysine in their active sites to coordinate the catalytic metal.[1] So while most carbamylation in a research sample is unwanted, accidental and effectively one-way, the modification is not simply chemical wreckage — it is a group that biology both installs and, in at least one case, removes.
In the labThe sample-preparation artifact
For anyone handling peptides and proteins analytically, carbamylation is best known as a hazard of sample preparation. Urea is one of the most useful denaturants in the laboratory, and precisely because a working buffer can be six to eight molar in urea, it is also a standing reservoir of cyanate.
The failure mode is simple. Dissolve a protein in a urea buffer, warm it to speed a digestion or a reduction step, let it stand, and some of the ever-present cyanate carbamylates the protein's lysines and N-termini as the preparation proceeds.[1] The consequences cascade through an experiment: carbamylation is described as a major artifact in proteomic analyses, where it blocks the trypsin cleavage that the workflow depends on, disrupts chemical labelling chemistries that also target lysine amines, and shifts a peptide's mass, charge and retention time so that it no longer matches the expected target.[1] Because accidental carbamylation competes for the same lysine amines that acetyl-lysine enrichment antibodies recognise, carbamylated peptides can even contaminate experiments aimed at a completely different modification.[1]
The mitigations all attack the cyanate supply or the time and temperature that let it react. Using freshly prepared urea and keeping sample preparation at room temperature reduces carbamylation, because urea decomposes to cyanate faster when it is old and when it is heated.[1][11] Removing urea before the digestion step — by buffer exchange, dialysis, or a filter-aided protocol — cuts off the supply, and some workflows replace urea entirely with a different detergent to avoid the problem from the start, with one study reporting a reduction of more than two-thirds in carbamylated lysines when a deoxycholate-based preparation was used in place of urea.[1] The same logic explains a storage principle that applies beyond urea buffers: reactions that slowly alter a peptide are held back by keeping it cold, dry and away from the reactive partners that drive them, the theme of How Peptides Degrade and Cold-Chain Peptide Storage.
The analyticsHow carbamylation is detected
Detecting carbamylation means catching a +43 dalton tag and proving it is not something else. The central tool is liquid chromatography coupled to mass spectrometry, backed up by targeted assays for homocitrulline and by antibodies.
In a bottom-up workflow, a protein is digested and the peptides are analysed by LC-MS/MS; a carbamylated residue shows up as the +43.005814 dalton addition on a lysine, arginine, cysteine or N-terminus, localised to a specific position by the fragmentation pattern.[2] High resolution is what makes the call trustworthy, because of the eight-millidalton gap from the acetylation isotope peak discussed above.[1] One complication is that, unlike acetyl-lysine, which produces a well-known diagnostic immonium fragment ion that confirms it in most spectra, carbamylation has no equally established diagnostic fragment, so identification leans more heavily on the precise precursor mass and the site localisation.[1] For a quantitative readout rather than a site map, a sample can be hydrolysed to free amino acids and its homocitrulline measured against lysine by LC-MS/MS, giving a homocitrulline-to-lysine ratio that expresses the overall degree of carbamylation.[3][8] Finally, antibodies raised against carbamyl-lysine or homocitrulline allow carbamylation to be detected by immunoblotting, immunoprecipitation and staining, provided they are validated not to cross-react with citrulline.[2] The chromatographic side of this work is covered in What Is HPLC, and the related analytical separations in What Is Amino Acid Analysis.
The biologyThe biology: inflammation, kidneys and aging
The same chemistry that bedevils a urea buffer runs continuously inside the body, and studying it is why carbamylation is more than an analytical footnote. Because the reaction is driven by urea and by inflammation, both of which vary with health, the slow build-up of carbamylated protein in tissue has become a window onto several conditions. The account that follows is background biology about proteins in living systems; it is not about any product.
The clearest driver is urea. In chronic kidney disease, urea is not cleared efficiently and rises in the blood, so the cyanate in equilibrium with it rises too, and carbamylated proteins accumulate.[5] Because the modification is slow and cumulative, carbamylated proteins behave like a time-averaged record of urea exposure, in the same way that glycated haemoglobin records average glucose. Carbamylated albumin in particular has been studied as a marker, and higher levels were associated with mortality risk in patients with kidney failure in one widely cited study; global protein carbamylation has likewise been linked to outcomes in end-stage renal disease.[6][7] The second driver is inflammation, through myeloperoxidase: at sites of inflammation and within atherosclerotic plaque, activated white cells generate cyanate from thiocyanate, carbamylating nearby proteins. The landmark demonstration of this route tied protein carbamylation to inflammation, smoking and uraemia and showed that carbamylated LDL could drive processes relevant to atherosclerosis.[4][8] Related peroxidase chemistry carbamylates proteins at other inflammatory sites, including in the airway.[14]
The slowest and most universal version is aging. Because stable carbamylation is essentially permanent, it piles up most on the longest-lived proteins — the collagens and elastins of connective tissue that turn over over years. A study measuring homocitrulline across species found that it accumulates with age in skin collagen and that tissue carbamylation is inversely related to species lifespan, leading the authors to describe protein carbamylation as a hallmark of aging.[3] Carbamylation has an immunological dimension as well: antibodies that recognise carbamylated proteins, known as anti-CarP antibodies, are found in a large fraction of rheumatoid-arthritis patients and are studied as markers there.[9] Even a historical thread connects to this chemistry, in that cyanate was once investigated as a way to deliberately carbamylate haemoglobin.[3] Across all of these, the molecular event is the one this guide describes: isocyanic acid, a carbamoyl group, and a lysine turned into homocitrulline.
Honest limitsWhat this guide does not establish
This guide is an educational account of a chemical reaction and the analytics around it. Several limits are worth stating plainly.
- It describes chemistry, not any product. Whether, where and how much any specific peptide carries a carbamylation is a property of an individual material and its certificate of analysis, not something that can be inferred from a compound's name.
- The mass values are arithmetic, not measurements of a product. Figures such as about 43.0058 daltons for a carbamoyl group follow from the atoms involved; they describe the modification, not any particular vial.
- The biology is about endogenous proteins. The sections on kidney disease, atherosclerosis, inflammation and aging describe the carbamylation of the body's own proteins as studied in the scientific literature. They are not statements about any research compound, are not medical advice, and imply nothing about use in a person or animal.
- Nothing here describes use in humans or animals. No dose, protocol or application is given or implied, and the handling points are laboratory sample-preparation and storage principles only.
- Nothing here concerns where any peptide is synthesised. The chemistry of carbamylation is general; it is not a claim about the origin of any specific material.
Frequently asked questions
What is carbamylation?
Carbamylation is a non-enzymatic chemical modification in which isocyanic acid adds a carbamoyl group (–CO–NH₂) to a reactive group on a protein or peptide. Its signature target is the ε-amino group of a lysine side chain, which it converts into homocitrulline (carbamyl-lysine); it also reacts with N-terminal amines and, reversibly, with cysteine thiols. The reactive isocyanic acid comes mainly from the spontaneous breakdown of urea into cyanate, and the modification adds about 43 daltons to the molecule.
What is homocitrulline?
Homocitrulline, also called carbamyl-lysine, is the product of carbamylating the ε-amino group of a lysine residue: the amine is capped with a carbamoyl group to form a neutral ureido side chain. It is the most characteristic marker of carbamylation and is chemically almost identical to citrulline, the product of modifying arginine; the two differ by a single additional methylene (CH₂) group in homocitrulline.
What is the difference between carbamylation and acetylation?
Both modifications cap a lysine's positive amine and neutralise its charge, but they add different groups and different masses. Acetylation adds an acetyl group and about 42.011 daltons; carbamylation adds a carbamoyl group and about 43.006 daltons, roughly one dalton heavier. The catch for mass spectrometry is that the heavy-carbon isotope peak of an acetylated peptide falls only about 8 millidaltons away from a carbamylated peptide, so high-resolution instruments are needed to tell them apart.
Does urea cause carbamylation?
Yes. In aqueous solution urea is in a slow equilibrium with ammonium cyanate, and cyanate is converted to the reactive species isocyanic acid, which carbamylates amines and thiols. This is why urea-based buffers are a well-known source of carbamylation in the laboratory, especially when they are old, concentrated or heated. Freshly prepared urea kept at room temperature minimises the reaction, and some workflows replace urea entirely to avoid it.
What is the mass shift of carbamylation?
Carbamylation adds a carbamoyl group, the atoms of isocyanic acid (CHNO), for a monoisotopic mass increase of about 43.0058 daltons, reported in proteomic datasets as a +43.005814 Da modification of lysine, arginine, cysteine or a peptide N-terminus. This is close to, but distinct from, the +42.011 Da of acetylation and the roughly +28 Da of a double methylation, which is why the exact mass is used to identify it.
What is the difference between carbamylation and citrullination?
They produce chemically similar neutral ureido groups but start from different residues and happen by different routes. Citrullination is an enzyme-driven conversion of arginine into citrulline that removes an amine and adds about 0.984 daltons. Carbamylation is a non-enzymatic capping of lysine (or an N-terminus) by isocyanic acid that forms homocitrulline and adds about 43 daltons. Homocitrulline from carbamylation and citrulline from citrullination differ by a single methylene group.
How is carbamylation detected?
Chiefly by liquid chromatography coupled to mass spectrometry, which reads the +43 Da mass tag on a lysine, arginine, cysteine or N-terminus and uses high resolution to separate it from the near-identical heavy isotope of acetylation. The homocitrulline content of a hydrolysed sample can also be quantified by LC-MS/MS as a homocitrulline-to-lysine ratio, and antibodies raised against carbamyl-lysine or homocitrulline are used for immunoblotting and staining.
SourcesReferences
- You, Y., Many, G., & Nakayasu, E. S. (2025). Protein carbamylation and proteomics: from artifacts to elucidation of biological functions. Frontiers in Analytical Science, 4, 1512573. doi:10.3389/frans.2024.1512573
- Claxton, J. S., Sandoval, P. C., Liu, G., Chou, C.-L., Hoffert, J. D., & Knepper, M. A. (2013). Endogenous carbamylation of renal medullary proteins. PLoS ONE, 8(12), e82655. doi:10.1371/journal.pone.0082655
- Gorisse, L., Pietrement, C., Vuiblet, V., Schmelzer, C. E. H., Köhler, M., Duca, L., Debelle, L., Fornès, P., Jaisson, S., & Gillery, P. (2016). Protein carbamylation is a hallmark of aging. Proceedings of the National Academy of Sciences, 113(5), 1191–1196. doi:10.1073/pnas.1517096113
- Wang, Z., Nicholls, S. J., Rodriguez, E. R., Kummu, O., Hörkkö, S., Barnard, J., et al. (2007). Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nature Medicine, 13(10), 1176–1184. doi:10.1038/nm1637
- Verbrugge, F. H., Tang, W. H. W., & Hazen, S. L. (2015). Protein carbamylation and cardiovascular disease. Kidney International, 88(3), 474–478. doi:10.1038/ki.2015.166
- Koeth, R. A., Kalantar-Zadeh, K., Wang, Z., Fu, X., Tang, W. H. W., & Hazen, S. L. (2013). Protein carbamylation predicts mortality in ESRD. Journal of the American Society of Nephrology, 24(5), 853–861. doi:10.1681/ASN.2012030254
- Berg, A. H., Drechsler, C., Wenger, J., Buccafusca, R., Hod, T., Kalim, S., et al. (2013). Carbamylation of serum albumin as a risk factor for mortality in patients with kidney failure. Science Translational Medicine, 5(175), 175ra29. doi:10.1126/scitranslmed.3005218
- Delporte, C., Boudjeltia, K. Z., Noyon, C., Furtmüller, P. G., Nuyens, V., Slomianny, M.-C., et al. (2018). Myeloperoxidase-catalyzed oxidation of cyanide to cyanate: a potential carbamylation route involved in the formation of atherosclerotic plaques? Journal of Biological Chemistry, 293(17), 6374–6386. doi:10.1074/jbc.M117.801076
- Shi, J., Knevel, R., Suwannalai, P., van der Linden, M. P., Janssen, G. M. C., van Veelen, P. A., et al. (2011). Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. Proceedings of the National Academy of Sciences, 108(42), 17372–17377. doi:10.1073/pnas.1114465108
- Hu, S.-H., et al. (2023). Amino acids downregulate SIRT4 to detoxify ammonia through the urea cycle. Nature Metabolism, 5(4), 626–641. doi:10.1038/s42255-023-00784-0
- Wiśniewski, J. R., Zougman, A., Nagaraj, N., & Mann, M. (2009). Universal sample preparation method for proteome analysis. Nature Methods, 6(5), 359–362. doi:10.1038/nmeth.1322
- Marier, J. R., & Rose, D. (1964). Determination of cyanate, and a study of its accumulation in aqueous solutions of urea. Analytical Biochemistry, 7(3), 304–314. doi:10.1016/0003-2697(64)90135-6
- Stark, G. R., Stein, W. H., & Moore, S. (1960). Reactions of the cyanate present in aqueous urea with amino acids and proteins. Journal of Biological Chemistry, 235, 3177–3181.
- Wang, Z., DiDonato, J. A., Buffa, J., Comhair, S. A., Aronica, M. A., Dweik, R. A., et al. (2016). Eosinophil peroxidase catalyzed protein carbamylation participates in asthma. Journal of Biological Chemistry, 291(42), 22118–22135.
- Stanfill, B. A., et al. (2018). Quality control analysis in real-time (QC-ART): carbamylation and other artifacts in proteomic sample preparation. Molecular & Cellular Proteomics, 17(9).
For the closely related modifications that share this chemistry, see What Is Citrullination, What Is Deamidation in Peptides and What Is Acetylation in Peptides; for how the +43 tag is read and the charge change is measured, see What Is Mass Spectrometry and What Is the Isoelectric Point.
All Patriot Labs products are sold strictly for in-vitro research and laboratory use only. Not for human or veterinary consumption. This guide is educational and describes the chemistry and analysis of carbamylation in general terms; it is not medical advice, does not describe how to use any product, and makes no claim about the composition, modification state or manufacturing location of any specific product.